Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Virella

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Clinical Immunology (Orlando, Fla.)|July 11, 2017
Immune complexes containing malondialdehyde (MDA) LDL induce apoptosis in human macrophagesGabriel Virella, Kelsey Wilson, Johnathon Elkes, et al.
Journal of Diabetes and Its Complications|December 3, 2014
The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetesHussein A Rajab, Nathaniel L Baker, Kelly J Hunt, et al.
Diabetes Care|November 10, 2017
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 DiabetesNathaniel L Baker, Kelly J Hunt, Danielle R Stevens, et al.
Journal of Diabetes and Its Complications|July 8, 2010
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclassesRichard L Klein, Rickey E Carter, Alicia J Jenkins, et al.
Atherosclerosis|March 15, 2006
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetesMaria F Lopes-Virella, Michael Brent McHenry, Stuart Lipsitz, et al.
Atherosclerosis|July 4, 2008
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cellsSamar M Hammad, Waleed O Twal, Jeremy L Barth, et al.
Metabolism: Clinical and Experimental|August 5, 2014
Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetesRichard L Klein, Samar M Hammad, Nathaniel L Baker, et al.
Diabetes Care|July 17, 2008
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complicationsMaria F Lopes-Virella, Rickey E Carter, Gregory E Gilbert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2005
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohortAklilu A Yishak, Tina Costacou, Gabriel Virella, et al.
Plos One|September 9, 2010
Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stressMohammed M Al Gadban, Kent J Smith, Farzan Soodavar, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Immunology (Orlando, Fla.)|July 11, 2017
Immune complexes containing malondialdehyde (MDA) LDL induce apoptosis in human macrophagesGabriel Virella, Kelsey Wilson, Johnathon Elkes, et al.
Journal of Diabetes and Its Complications|December 3, 2014
The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetesHussein A Rajab, Nathaniel L Baker, Kelly J Hunt, et al.
Diabetes Care|November 10, 2017
Association Between Inflammatory Markers and Progression to Kidney Dysfunction: Examining Different Assessment Windows in Patients With Type 1 DiabetesNathaniel L Baker, Kelly J Hunt, Danielle R Stevens, et al.
Journal of Diabetes and Its Complications|July 8, 2010
LDL-containing immune complexes in the DCCT/EDIC cohort: associations with lipoprotein subclassesRichard L Klein, Rickey E Carter, Alicia J Jenkins, et al.
Atherosclerosis|March 15, 2006
Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetesMaria F Lopes-Virella, Michael Brent McHenry, Stuart Lipsitz, et al.
Atherosclerosis|July 4, 2008
Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cellsSamar M Hammad, Waleed O Twal, Jeremy L Barth, et al.
Metabolism: Clinical and Experimental|August 5, 2014
Decreased plasma levels of select very long chain ceramide species are associated with the development of nephropathy in type 1 diabetesRichard L Klein, Samar M Hammad, Nathaniel L Baker, et al.
Diabetes Care|July 17, 2008
Risk factors related to inflammation and endothelial dysfunction in the DCCT/EDIC cohort and their relationship with nephropathy and macrovascular complicationsMaria F Lopes-Virella, Rickey E Carter, Gregory E Gilbert, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 8, 2005
Novel predictors of overt nephropathy in subjects with type 1 diabetes. A nested case control study from the Pittsburgh Epidemiology of Diabetes Complications cohortAklilu A Yishak, Tina Costacou, Gabriel Virella, et al.
Plos One|September 9, 2010
Differential trafficking of oxidized LDL and oxidized LDL immune complexes in macrophages: impact on oxidative stressMohammed M Al Gadban, Kent J Smith, Farzan Soodavar, et al.
Pageof 5